Last $24.42 USD
Change Today -0.03 / -0.12%
Volume 1.4M
IDIX On Other Exchanges
Symbol
Exchange
IDIX is not on other exchanges.
As of 5:20 PM 07/31/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Stefano Vella M.D.

Member of HIV Scientific Advisory Board, Idenix Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 26 board members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background*

Stefano Vella M.D. is a Member of the HIV Scientific Advisory Board of Idenix Pharmaceuticals Inc. Dr. Vella serves as a Director of Instituto Superiore di Samita, Rome, Italy.

Corporate Headquarters*

320 Bent Street
Cambridge, Massachusetts 02141

United States

Phone: 617-995-9800
Fax: 617-995-9801

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

There is no Company Affiliations data available.

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IDIX:US $24.42 USD -0.03

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IDENIX PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.